E. Mitry, B. Guiu, S. Cosconea, V. Jooste, J. Faivre et al., Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study, Gut, vol.59, issue.10, pp.1383-1391, 2010.
DOI : 10.1136/gut.2010.211557

H. Kobayashi, H. Mochizuki, K. Sugihara, T. Morita, K. Kotake et al., Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: A multicenter study, Surgery, vol.141, issue.1, pp.67-75, 2007.
DOI : 10.1016/j.surg.2006.07.020

C. Fuchs, J. Marshall, and J. Barrueco, Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Updated Results From the BICC-C Study, Journal of Clinical Oncology, vol.26, issue.4, pp.689-90, 2008.
DOI : 10.1200/JCO.2007.15.5390

P. Artru, J. Desramé, and G. Lledo, Cancer colorectal métastatique : place de la pause et du traitement d'entretien. Hépato-­?Gastro Oncol Dig, pp.303-313, 2015.

J. Pfannschmidt, T. Muley, H. Hoffmann, and H. Dienemann, Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: Experiences in 167 patients, The Journal of Thoracic and Cardiovascular Surgery, vol.126, issue.3, pp.732-741, 2003.
DOI : 10.1016/S0022-5223(03)00587-7

T. Yan, J. King, A. Sjarif, D. Glenn, K. Steinke et al., Percutaneous Radiofrequency Ablation of Pulmonary Metastases from Colorectal Carcinoma: Prognostic Determinants for Survival, Annals of Surgical Oncology, vol.76, issue.11, pp.1529-1566, 2006.
DOI : 10.1245/s10434-006-9101-1

O. Connell, J. Maggard, M. Ko, and C. , Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging, JNCI Journal of the National Cancer Institute, vol.96, issue.19, pp.1420-1425, 2004.
DOI : 10.1093/jnci/djh275

P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan et al., New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada, J Natl Cancer Inst Feb, vol.292, issue.3, pp.205-221, 2000.

A. Trotti, A. Colevas, A. Setser, V. Rusch, D. Jaques et al., CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment, Seminars in Radiation Oncology, vol.13, issue.3, pp.176-81, 2003.
DOI : 10.1016/S1053-4296(03)00031-6

J. Ferguson, N. Alzahrani, J. Zhao, D. Glenn, M. Power et al., Long term results of RFA to lung metastases from colorectal cancer in 157 patients, European Journal of Surgical Oncology (EJSO), vol.41, issue.5, pp.690-695
DOI : 10.1016/j.ejso.2015.01.024

E. Petre, X. Jia, R. Thornton, C. Sofocleous, W. Alago et al., Treatment of Pulmonary Colorectal Metastases by Radiofrequency Ablation, Clinical Colorectal Cancer, vol.12, issue.1, 2013.
DOI : 10.1016/j.clcc.2012.07.003

T. Chua, A. Zhao, J. Glenn, D. Liauw, W. Morris et al., Radiofrequency Ablation of Concomitant and Recurrent Pulmonary Metastases after Surgery for Colorectal Liver Metastases, Annals of Surgical Oncology, vol.230, issue.1, p.60
DOI : 10.1245/s10434-011-1859-0

Y. Takakura, Y. Miyata, M. Okajima, M. Okada, and H. Ohdan, Short disease-free interval is a significant risk factor for intrapulmonary recurrence after resection of pulmonary metastases in colorectal cancer, Colorectal Disease, vol.12, issue.7, 2010.
DOI : 10.1111/j.1463-1318.2009.02070.x

M. Onaitis, R. Petersen, J. Haney, L. Saltz, B. Park et al., Prognostic Factors for Recurrence After Pulmonary Resection of Colorectal Cancer Metastases, The Annals of Thoracic Surgery, vol.87, issue.6, 2009.
DOI : 10.1016/j.athoracsur.2009.03.034

U. Landes, J. Robert, T. Perneger, G. Mentha, V. Ott et al., Predicting survival after pulmonary metastasectomy for colorectal cancer: previous liver metastases matter, BMC Surgery, vol.33, issue.Suppl 1, p.17, 2010.
DOI : 10.1007/s00268-008-9875-3

A. Gillams, Z. Khan, P. Osborn, and W. Lees, Survival after Radiofrequency Ablation in 122 Patients with Inoperable Colorectal Lung Metastases, CardioVascular and Interventional Radiology, vol.76, issue.3, 2013.
DOI : 10.1007/s00270-012-0500-3

C. Tournigand, A. Cervantes, A. Figer, G. Lledo, M. Flesch et al., OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer???A GERCOR Study, Journal of Clinical Oncology, vol.24, issue.3, pp.394-400, 2006.
DOI : 10.1200/JCO.2005.03.0106

B. Chibaudel, F. Maindrault-­?goebel, G. Lledo, L. Mineur, T. André et al., Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study, Journal of Clinical Oncology, vol.27, issue.34, pp.5727-5760, 2009.
DOI : 10.1200/JCO.2009.23.4344

H. Wasan, A. Meade, R. Adams, R. Wilson, C. Pugh et al., Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial, The Lancet Oncology, vol.15, issue.6, pp.631-640, 2014.
DOI : 10.1016/S1470-2045(14)70106-8

L. Simkens, H. Van-tinteren, A. May, A. Tije, . Ten et al., Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group, The Lancet, vol.385, issue.9980, pp.1843-52, 2009.
DOI : 10.1016/S0140-6736(14)62004-3

T. Iida, H. Nomori, M. Shiba, J. Nakajima, S. Okumura et al., Prognostic Factors After Pulmonary Metastasectomy for Colorectal Cancer and Rationale for Determining Surgical Indications, Annals of Surgery, vol.257, issue.6, pp.1059-64
DOI : 10.1097/SLA.0b013e31826eda3b

J. Pfannschmidt, H. Hoffmann, and H. Dienemann, Reported Outcome Factors for Pulmonary Resection in Metastatic Colorectal Cancer, Journal of Thoracic Oncology, vol.5, issue.6
DOI : 10.1097/JTO.0b013e3181dca330

T. Hiraki, H. Gobara, T. Iishi, Y. Sano, T. Iguchi et al., Percutaneous Radiofrequency Ablation for Pulmonary Metastases from Colorectal Cancer: Midterm Results in 27 Patients, Journal of Vascular and Interventional Radiology, vol.18, issue.10, pp.1264-1273, 2007.
DOI : 10.1016/j.jvir.2007.06.027

J. King, D. Glenn, W. Clark, J. Zhao, K. Steinke et al., Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer, British Journal of Surgery, vol.91, issue.2, 2004.
DOI : 10.1002/bjs.4392

T. Hiraki, H. Gobara, T. Iguchi, H. Fujiwara, Y. Matsui et al., Radiofrequency ablation as treatment for pulmonary metastasis of colorectal cancer, World Journal of Gastroenterology, vol.20, issue.4, 2014.
DOI : 10.3748/wjg.v20.i4.988

T. Yan, J. King, A. Sjarif, D. Glenn, K. Steinke et al., Treatment Failure After Percutaneous Radiofrequency Ablation for Nonsurgical Candidates With Pulmonary Metastases From Colorectal Carcinoma, Annals of Surgical Oncology, vol.16, issue.5, pp.1718-1744, 2007.
DOI : 10.1245/s10434-006-9271-x

Y. Yamauchi, Y. Izumi, M. Kawamura, S. Nakatsuka, H. Yashiro et al., Percutaneous Cryoablation of Pulmonary Metastases from Colorectal Cancer, PLoS ONE, vol.102, issue.11, p.27086, 2011.
DOI : 10.1371/journal.pone.0027086.t002

S. Smith and P. Jennings, Lung radiofrequency and microwave ablation: a review of indications, techniques and post-procedural imaging appearances, The British Journal of Radiology, vol.88, issue.1046, 2015.
DOI : 10.1259/bjr.20140598